Submit Science

Updated:Jul 24,2014
Scientific Sessions 2014 - grow your career and knowledge

Submit Science

Become a Member

Join or renew your AHA/ASA Professional Membership today to save on registration for all AHA Scientific Sessions.
Abstract Submission

Late Breaking Basic Science Abstract Submission is now open through August 18, 2014 at 5 p.m. CDT | UTC -5.
Registration Information

Registration and Housing dates:

FAHA/VIP: June 11
Members/Media: June 18
Nonmembers: June 25
Exhibitors/Group: July 9

Register for Scientific Sessions 2014 (opens in new window)

     Science Submissions:
The American Heart Association is soliciting abstracts describing highly meritorious, high impact science.  Emphasis will be given to genuine innovation and fundamental, distinctive, novel research. Abstracts will be evaluated on the basis of their impact and novelty.  Abstracts submitted in June, but rejected, or revisions of such abstract will not be considered in this Late-Breaking Basic Science abstracts call. Select the button below for more information (PDF).

Submission Guidelines
  • Abstract Submissions for Scientific Sessions 2014 and ReSS 2014 are now closed.
  • Late-Breaking Clinical Trial Submissions are now closed.

4 Reasons to Submit Your Science This Year:


Click below for more information (PDFs)

Submission Guidelines  Best Practices  Abstract Categories 

Scientific Sessions: Why Submit?

Opportunity for Publication:
  • Accepted abstracts are published in Circulation, an American Heart Association journal Circulation continues to be one of the top journals for Impact Factor, 5-Year Impact Factor, Article Influence® Score, and Eigenfactor® Score and total cites among all 122 journals in the Cardiac & Cardiovascular Systems and 67 journals in the Peripheral Vascular Diseases subject categories, according to the 2012 Journal Citation Reports® (Thomson Reuters, 2013).
Member Benefits:
  • Member benefits include more than $160,000.00 in council awards and travel grants available to professional members, early career investigators, trainees and students submitting abstracts to Scientific Sessions. Visit  and view the Awards & Lectures available for Scientific Sessions. To join AHA membership please visit
Global Reach:
  • Your accepted abstracts could receive international coverage from major media outlets.
  • 2013 abstracts were featured in the Associated Press, USA Today, Fox News, BBC,, Reuters wire service and U.S. News & World Report.
  •  In all, there were more than 8 billion media impressions* for Scientific Sessions 2013, in addition to 5.2 million in social media impressions.
  •  Discuss your study findings with more than 17,000 attendees on-site and share your findings with more than 1.5 million virtual professional attendees.
*5.8 billion impressions from AHA/ACC guidelines that were presented at Sessions 2013 meeting




Late-Breaking Basic Science

These innovative abstracts will provide the latest breakthroughs in basic science, presenting cutting-edge, exciting and pivotal research results.  The submission period is July 24 – August 18, 2014. Select the button below for more information (PDF).

Submission Guidelines

Late-Breaking Clinical Trials

Late-Breaking Clinical Trials sessions are innovative, provide the latest breakthroughs in clinical science and potentially will have a significant impact on clinical practice.  Clinical Science Report sessions will highlight trial updates, registries and important clinical science.   The submission period is June 2 – June 23, 2014. Click the button below for more information (PDF).

Submission Guidelines

Embargo Policy

Abstracts and presentations are embargoed for release at date and time of presentation or time of AHA news event. Written embargoed information cannot be shared with anyone but one-on-one embargoed media interviews can be conducted as long as the reporter agrees to abide by the embargo policy. Failure to honor embargo policies will result in the abstract being withdrawn and barred from presentation. View the complete AHA/ASA General Embargo Policies.